Rivent (LTHM – (Free Report) recently appeared on the list of most searched stocks on Zacks.com. Therefore, you may need to consider some important factors that may influence the stock’s performance in the near future.
Shares of this supplier of high-performance lithium compounds have changed -19.4% over the past month, compared to a -5.2% change in the Zacks S&P 500 Composite Index. The Zacks Chemical – Specialty industry, which includes Rivent, has declined 4.8% in this period. The key question here is where the stock is likely to go in the short term.
While media reports and rumors about significant changes in a company’s business outlook typically trigger stock price trends and lead to immediate price movements, there are always certain fundamental factors that ultimately drive the buy-and-hold decision. Exists.
Regarding revisions to performance forecasts
At Zacks, we prioritize evaluating changes in company earnings estimates rather than focusing on anything else. This is because we believe that the fair value of a stock is determined by the present value of its future income stream.
Our analysis is fundamentally based on how the sell-side analysts covering a given stock are revising their earnings estimates to account for the latest business trends. As a company’s earnings expectations rise, so does the fair value of its stock. And when a stock’s fair value is higher than its current market price, investors tend to buy the stock, which causes the stock price to rise. For this reason, empirical research has shown that there is a strong correlation between trends in earnings forecast revisions and short-term stock price movements.
Livent is expected to post earnings of $0.47 per share for the current quarter, representing a year-over-year change of +14.6%. Over the past 30 days, the Zacks Consensus Estimate has changed by -1.5%.
The consensus earnings estimate for the current fiscal year of $2.14 represents a year-over-year change of +52.9%. This estimate has changed -0.6% over the past 30 days.
Next year’s consensus earnings estimate of $2.50 represents a +17.1% change from the earnings Livent was expected to report a year ago. Over the past month, the forecast has changed by -2.3%.
The Zacks Rank, a proprietary stock evaluation tool with an impressive, outside-audited track record of impressive results, harnesses the power of earnings estimate revisions to be a more conclusive indicator of a stock’s short-term price performance. . The magnitude of the recent consensus estimate change, along with three other factors related to the earnings estimate, has led to Livent’s Zacks Rank #3 (Hold).
The chart below shows the company’s consensus EPS estimate over the next 12 months over time.
12 months EPS
Expected revenue growth rate
There’s no question that a company’s profit growth is the best indicator of its financial health, but nothing will happen if it doesn’t make a profit. It’s nearly impossible for a company to expand its bottom line without growing it over the long term. Therefore, it’s important to know a company’s earnings growth potential.
For Livent, the current quarter’s consensus revenue estimate of $274.37 million represents a year-over-year change of +18.5%. His $1.07 billion and $1.35 billion forecasts for the current and next fiscal year represent changes of +32% and +25.4%, respectively.
Last reported results and surprising details
Livent reported revenue of $235.8 million in its last reported quarter. This represents a +7.8% year-over-year change. EPS for the same period was $0.51, compared to $0.37 a year ago.
The reported earnings represent a surprise of -8.25% when compared to the Zacks Consensus Estimate of $257 million. EPS surprise was +10.87%.
Over the last four quarters, Livent has surpassed consensus EPS estimates three times. He’s the only time the company has exceeded consensus revenue estimates during this period.
evaluation
You cannot make efficient investment decisions without considering stock valuation. To predict a stock’s future price performance, it is important to determine whether the current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects.
Compare the current value of a company’s valuation multiples, such as price to earnings (P/E), price to sales (P/S), and price to cash flow (P/CF), to its own value, while also Value helps determine whether a stock is fairly valued, overvalued, or undervalued, and by comparing a company to its peers based on these parameters, you can determine whether a stock is reasonably priced. I can understand the gender.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) categorizes stocks into five groups, ranging from A to F, with A ranging from B to F. B is better than C, and so on), and can help identify whether a stock is overvalued, fairly valued, or temporarily undervalued. Masu.
Livent is rated A on this score, indicating that it trades at a discount to its peers. Click here to see the values of some of the metrics that determined this grade.
conclusion
The facts discussed here, and much of the other information on Zacks.com, may help you decide whether the market buzz surrounding Livent is worth paying attention to. However, the company’s Zacks Rank #3 suggests it could outperform the broader market in the near term.
Zacks goes public with ChatGPT’s ‘Sleeper’ stock
A little-known company is at the center of a particularly bright field of artificial intelligence. By 2030, the AI industry is predicted to have an economic impact of $15.7 trillion on the Internet and iPhone scale.
As a service to our readers, Zacks is offering a bonus report that lists and discusses this explosive growth stock and four other “stocks to buy.” Even more.
Download ChatGPT stock report for free now >>